Found 5 matching trials
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma PHASE1 This phase I/II trial studies the side effects of infliximab and vedolizuma...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning PHASE2 This phase II trial studies how well vedolizumab plus post-transplant cyclo...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease PHASE4 There are currently three classes of biologic treatments approved in Canada...
Show More Location
University of Calgary
Learn More & Join Trial
Vedolizumab Post Op Study PHASE2 This is a pilot study that will determine the endoscopic recurrence of Croh...
Show More Location
University of Pittsburgh
Learn More & Join Trial
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer PHASE1 This trial studies the role of the gut microbiome and effectiveness of a fe...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial